AMGN
23
-3
KMB
44
2
EXPE
81
-2
JPM
60
-9
EW
51
-2
HCA
66
2
PH
73
-4
CB
65
4
WU
41
2
ETR
52
-2
VIX
49
3
AES
57
2
BF.B
54
-4
KIM
60
2
MHK
40
-3
VTR
70
-5
DG
72
4
AON
58
2
DHR
63
-3
NAVI
19
-13
AMGN
23
-3
KMB
44
2
EXPE
81
-2
JPM
60
-9
EW
51
-2
HCA
66
2
PH
73
-4
CB
65
4
WU
41
2
ETR
52
-2
VIX
49
3
AES
57
2
BF.B
54
-4
KIM
60
2
MHK
40
-3
VTR
70
-5
DG
72
4
AON
58
2
DHR
63
-3
NAVI
19
-13
Financhill
Back

Crown Holdings, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
34

CCK
Crown Holdings, Inc.

Last Price:
$95.03
Seasonality Move:
17.55%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
34
Crown Holdings, Inc. (CCK) is a Sell

Is Crown Holdings, Inc. a Buy, Sell or Hold?

  • The current Crown Holdings, Inc. [CCK] share price is $94.20. The Score for CCK is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CCK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CCK Stock Price Chart

What is Crown Holdings, Inc.'s stock price today?

  • The Crown Holdings, Inc. share price today is $94.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CCK is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CCK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 41.25 Sell
Chaikin Money Flow: -1598033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (95.58 - 98.96) Sell
Bollinger Bands (100): (94.16 - 100.7) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

CCK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.32 Sell
20-day SMA: 97.14 Sell
50-day SMA: 96.2 Sell
200-day SMA: 96.31 Sell
8-day EMA: 96.74 Sell
20-day EMA: 96.96 Sell
50-day EMA: 96.88 Sell
200-day EMA: 95.74 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Crown Holdings, Inc. Earnings Growth & CCK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $0.52 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Crown Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):